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Abstract: 
Objective: To measure the concentration and role of malondialdehyde to determine oxidative stress in 
rheumatoid arthritis patients and comparing them with healthy individuals. Methodology: This cross sectional 
study was conducted on 180 patients of age 49 to 70 years and both gender. Study was completed in the 
department of physiology Sheikh Zaid Medical College, Quid e Azam Medical college and Lahore General 
Hospital, from October 2017 to October 2018. Study was started after obtaining ethical approval and informed 
consent from the patients. SPSS version 23 was used to analyze data related to study. Continuous variables were 
presented as mean and standard deviation like age and Serum MDA concentration, categorical variables were 
presented as numbers and percentages like gender. Post operative chi square test was applied and p value less 
than or equal to 0.05 was considered as significant. Results: Overall, there were 100% (n=180) patients were 
included, in this study. The study group was further divided into two equal groups, 50% (n=90) in each, i.e. 
Rheumatoid arthritis (RA) group and control group. RA group patients include those diagnosed as rheumatoid 
arthritis clinically and through lab investigations and control group consist of normal healthy adults. The serum 
MDA levels in the RA patients were 3.97±1.03 nmoles/ml and it was 1.59±0.32 nmol/ml in control patients. The 
difference was statistically significant (t=20.87, p=0.001). Conclusion: the observations of our study showed 
statistically significant raised serum Malondialdehyde level as compared to control group.  
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Introduction: 
An inflammatory disease Rheumatoid Arthritis has capability of continuous destruction of synovial joints. This 
condition also known as synovitis which may include deterioration of bones and cartilage, some other are 
systemic like pulmonary, cardiovascular, psychological and skeletal system abnormalities. Prevalence of 
rheumatoid arthritis reported as 1% in literature worldwide1. 
Malondialdehyde (MDA) is a main contributing factor of DNA mutation in human and bacterial cells, it 
produces as a result of lipid peroxidation and also from biosynthesis of prostaglandins. MDA also reported as 
carcinogenic agent as reported in some studies conducted on rats. It was also reported that in Salmonella 
typhimurium MDA responsible for their gene mutation by affecting base substances. In Escherichia coli 
replication was observed on single standard M13 genome mutation (G→T, A→ G, and C→ T). These three 
modifications are possible in DNA as a result of MDA involvement. It was separated from tissues of healthy 
humans in form of M1G which was produced as a result of reaction with guanine2. 
Cytokinesand T cells in combination with oxygen radicals and hydrogen peroxide plays major role in 
progressive activity of macrophages and enhancement of Rheumatoid Arthritis. Nitrogen and oxygen species 
have both types of effects beneficial and harmful 3. Increased level of malonaldehyde (oxidative stress) is stage 
when reactive nitrogen and oxygen reaches to a damaging range and harm the cells and other biological body 
markers. When body’s mechanism of antioxidants and oxidative stress become imbalance it can cause serious 
autoimmune diseases like Rheumatoid Arthritis 4. Oxygen species in reactive form plays an important role in 
RA, main attack of these reactive oxygen molecule is unsaturated fatty acids. 
They damage nucleic acid, connective tissue and lipids of cell membrane, as a result of these damage free 
radicals and their result products cause inflammation by realizing mediators 5. In synovial joints, synovial fluids 
have chemo attractant property; this property leads to the anaerobic glycolysis and enhancement the oxygen 
consumption. This whole activity generates hydroxyl, hypochloricradicals and superoxide. Among all these 
components neutrophils are found to be active in synovial fluid and cause erosion when Rheumatoid Arthritis 
develops 6. 
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In lipid peroxidation malondialdehyde is an important factor and hallmark of Rheumatoid Arthritis diagnosis 7. 
In recent studies it was observed and suggested that early and right management of malondialdehyde reduced 
and delayed the incidence of Rheumatoid Arthritis. Vyas S et al8 conducted a study in 2016 and observed a 
significant increase in malondialdehyde level in serum of Rheumatoid Arthritis patients; p value was 0.0001 
which is significant. Determine the serum malondialhyde level in Rheumatoid Arthritis patients and to compare 
with normal and healthy patients is objective of our study 9. 
Methodology: 
This cross sectional  study was conducted on 180 patients of age 49 to 70 years and both gender. Study was 
completed in the department of physiology Sheikh Zaid Medical College, Quid e Azam Medical college and 
Lahore General Hospital, from October 2017 to October 2018. Study was started after ethical approval from 
institutions committee of ethics. Patients were divided into two equal groups (90 patients in each group). Non 
probability consecutive sampling technique was used. Sample size was calculated by using openepi.com an 
online source for sample size calculation. Complete physical examination, routine laoratoryand radiological 
investigations was done. Rheumatoid arthritis was confirmed by X ray, c reactive protein, antinuclear antibody 
and rheumatoid arthritis factor. Patients of normal healthy diet, no history of nutritional supplement and post and 
pre menopausal women were included in the study. Patients with known history of diabetes, hypertension, 
smokers, alcoholic, history of anti inflammatory dugs and any trauma to joint were excluded from the study. 
With all antiseptic measures 5 ml blood was drawn from anticubetal vein and sent to laboratory for laboratory 
investigation. Sampling tube was opened with care to avoid hemolysis. Blood was allowed to clot at room 
temperature for some time than serum was drawn after centrifugation (centrifugation was done at 3000 rpm for 
15-20 minutes in morning shift. Hemolytic samples were discarded. Thiobarbituric acid assay test was used to 
estimate MDA concentration. UV-VIS Spectrophotometer was used to calculate optical density. Thiobarbituric 
acid assay method measures Malondialdehyde by measuring aldehyde products of lipid peroxide. Exact 
mechanism behind this procedure is reaction of two molecules of thiobarbituric acid and one molecule of 
Malondialdehyde to make MDA-TBA red product which can be measured at 535 nm. 
SPSS version 23 was used to analyze data related to study. Continuous variables were presented as mean and 
standard deviation like age and Serum MDA concentration, categorical variables were presented as numbers and 
percentages like gender. Post operative chi square test was applied and p value less than or equal to 0.05 was 
considered as significant. 
Results: 
Overall, there were 100% (n=180) patients were included, in this study. The study group was further 
divided into two equal groups, 50% (n=90) in each, i.e. Rheumatoid arthritis (RA) group and control group. The 
Mean ± S.D age of RA patients was 54.61±4.61 years. While, the Mean± S.D age of the control patients was 
50.0±4.23 years. The difference was statistically significant (t=6.98, p=0.000). Gender distribution, in RA 
patients, was observed as 58.9% (n=53) males and 41.1% (n=37) females. While, in control patients, there were 
48.9% (n=44) males and 51.1% (n=46) females. The difference was statistically insignificant (χ2 =1.81, p=0.178) 
(Table. 1). 
The serum MDA levels in the RA patients were 3.97±1.03 nmoles /ml and it was 1.59±0.32 nmol/ml in 
control patients. The difference was statistically significant (t=20.87, p=0.000). (Table. 2). 
Table. 1 
Demographic characteristics of RAandcontrol patients 
Characteristics RA* 
(n=90) 
control 
(n=90) 
Test of Sig. 
Age 54.61±4.61 years 50.0±4.23 years t=6.98, p=0.000 
Gender M=58.9%, F=41.1% M=48.9%, F=51.1% χ2 =1.81, p=0.178 
* Rheumatoid arthritis 
 
 
 
Table-2 
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Mean Serum MDA concentration (nmoles/ml) in RA patients with that of controls 
 
Mean Serum MDA 
concentration 
RA* 
(n=90) 
Control 
(n=90) 
Test of Sig. 
Mean±S.D 3.97±1.03 nmoles/ml 1.59±0.32 nmol/ml t=20.87, p=0.000 
* Rheumatoid arthritis       * Malondialdehyde 
 
 Discussion: 
Rheumatoid arthritis may be due to increased level of oxidative stress and serum MDA. After this continuous 
increase in MDA, chain reaction starts which gives continuous free radicals for continuation and new cycle of 
per oxidation. This whole cycle produced a new mixture of MDA. In many previous studies level of MDA 
observed increased in rheumatoid arthritis patients as compare to normal adults 10. 
In our study it was observed that in RA patients there was 58.9% (n=53) males and 41.1% (n=37) females. RA 
was found in most of male patients. A similar study was conducted by Vyas S et al8 on Indian population in 2016 
and reported that RA was mostly found in female patients. In his study 16 male were diagnosed with RA and 34 
female. Findings of his study show that RA was common in female as compared to male population in India. 
These results are against our findings. In another study Fridlyand LE et al 9 also reported similar results that RA 
was mostly diagnosed in female subjects as compare to male and main contributing factor is increase in 
Malondialdehyde. Results of this study are also against our results and in favor of study conducted by Vyas S et 
al. Post menupausal arthritis changes in female patients were also assessed in some studies but thatis contributing 
factor of old age female. Malondialdehyde was found in all age groups. 
In our study in RA patients serum MDA found to be increased when compared with controls. Serum MDA levels 
in the RA patients were 3.97±1.03 nmoles/ml and it was 1.59±0.32 nmol/ml in control patients. The difference 
was statistically significant (t=20.87, p=0.000).  Our results similar to study conducted by Gambhir JK et al11 in 
1997 who found increased level MDA in serum of rheumatoid arthritis patients as compared to healthy controls, 
p<0.001. 
Similar studies were conducted by Mane KK et al12 in 1999 and Vyas S et al8 in 2016 and reported increased 
level of MDA in serum of rheumatoid arthritis patients. This increased serum MDA due to increased production 
of free radicals and oxidative stress in rheumatoid arthritis patients. Result of these two studies identical to our 
findings.  
Moti L Tiku13 and Jaswal S et al14 also conducted similar studies and reported that free radical production and 
peroxidation was found in patients of rheumatoid arthritis and osteoarthritis patients. These studies were also in 
favor of our findings. A study by Karatas F et al15 also supports our findings.  
Similarly studies conducted by Paliwal MN et al16 and Maneesh et al17 and reported similar results to our study. 
They found increased serum enzymatic antioxidant marker and lipid MDA as compare to healthy controls P< 
0.05. Results of these studies were significant and comparable to our results. Another similar study was 
conducted by El-barbary AM et al18 and reported similar finding.  
In our study we found that serum Malondialdehyde level was increased in patients of rheumatoid arthritis, 
similar results were reported by Lunec et al in his study, he revealed that serum uric acid concentration found to 
be increased in serum and synovial fluid of RA patients 19. Another study was conducted by Gambriz et al in 
1997 on topic of serum uric acid level in RA patients and reported that increase in serum uric acid concentration 
are the cause of RA specifically in aged patients 20. Another similar study was conducted by Chaturvedi et al 
1990 and reported similar finding that serum uric acid was increased in RA patient’s blood. Findings of these 
studies are comparable with our findings and goes in favor of our results 21. 
Conclusion: 
the observations of our study showed statistically significant raised serum Malondialdehyde level as compared to 
control group.  
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